Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine

Cephalalgia

Volumn 30, Issue 10, 2010, Pages 1187-1194

  Pinkerman, Brenda ^a   Holroyd, Kenneth ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Acute migraine therapy; Menstrual migraines; Menstrually related migraines; Migraine

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE; ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE; NAUSEA; NONMENSTRUAL MIGRAINE; PHONOPHOBIA; PHOTOPHOBIA; TREATMENT RESPONSE; VOMITING; CLASSIFICATION; COMPARATIVE STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMENSTRUAL SYNDROME; TREATMENT OUTCOME;

ADULT; ANALGESICS; FEMALE; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; PREMENSTRUAL SYNDROME; TREATMENT OUTCOME;

EID: 79952115347     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102409359315     Document Type: Article

References (53)

1. Martin V, Lipton R. Epidemiology and biology of men-strual migraine. Headache 2008; 48: S124-S130.
2. Beckham J, Krug L, Penzien D, et al. The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache 1992; 3: 292-297.
3. Dzoljic E, Sipetic S, Vlajinac H, et al. Prevalence of menstrually-related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002; 42: 193.
4. Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually-related migraine referred to headache centres. Cephalalgia 2004; 24: 707-716. (Pubitemid 39209074)
5. Couturier E, Bomhof M, Neven A, Knuistingh M, van Duijn N. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003; 23: 302-308. (Pubitemid 36577949)
6. Dowson A, Kilminster S, Salt R, Clark M, Bundy M. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache 2005; 45: 274-282. (Pubitemid 40530191)
7. Martin V, Wernke S, Mandell K, et al. Defining the rela-tionship between ovarian hormones and migraine head-ache. Headache 2005; 45: 1190-1201. (Pubitemid 350004908)
8. Diamond M, Cady R, Mao L, et al. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison ofmenstrually-related and nonmenstrually-related migraines. Headache 2008; 48: 248-258. (Pubitemid 351178257)
9. Stewart W, Lipton R, Chee E, Sawyer J, Silberstein S. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000; 55: 1517-1523.
10. Martin V, Cady R, Mauskop A, et al. Efficacy of riza-triptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) Studies. Headache 2008; 48: 226-235. (Pubitemid 351178285)
11. MacGregor E, Chia H, Vohrah R, Wilkinson M. Migraine and menstruation: a pilot study. Cephalalgia 1990; 10: 305-310
12. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. 2nd edn. Cephalalgia 2004; 24: 1-160.
13. MacGregor E, Hacksaw A. Prevalence of migraine on each day of the natural menstrual cycle. Headache 2004; 63: 351-353. (Pubitemid 38971141)
14. Bigal M, Sheftell F, Tepper S, Tepper D, Ho T, Rapoport A. A randomized double-blind study comparing rizatrip-tan, dexamethasone, and the combination of both in the acute treatment of menstrually-related migraine. Headache 2008; 48: 1286-1293.
15. Holroyd K, Chen Y. A hand-held computer headache diary program: Monitoring headaches, medication use and dis-ability in real time [abstract]. Headache 2000; 40: 412
16. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine. 2nd edn. Cephalalgia 2000; 20: 765-786.
17. Lipton R, Stewart W, von Korff M. Migraine impact and functional disability. Cephalalgia 1995; 15(Suppl 15): 4-9.
18. Liang K, Zeger S. Longitudinal data analysis using gen-eralized linear models. Biometrika 1986; 73: 13-22.
19. Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
20. SAS Institute. Version 8.2. Cary, NC, USA: SAS Institute, 2001.
21. Brown H, Prescott R. Sample size estimation: non-normal data. Applied mixed models in medicine. Chichester, UK: John Wiley & Sons, 1999, p.258.
22. Newman L, Harper S, Jones B, Campbell J. Frovatriptan for acute treatment of migraine associated with menstru-ation: results from an open-label postmarketing surveil-lance study. J Women's Health 2009; 18: 1265-1273.
23. Bigal M, Borucho S, Serrano D, Lipton R. The acute treatment of episodic and chronic migraine in USA. Cephalalgia 2009; 29: 891-897.
24. Haaga J. 'Educational attainment in Appalachia', http://webharvest.gov/ peth04/20041015124039/http://arc.gov/images/reports/prbeducation/attainment.pdf, Washington, DC: Population Reference Bureau/Appalachian Regional Comission, 2004 (accessed December 2009).
25. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1-96.
26. Solbach P, Waymer R. Treatment of menstruation-associated migraine headache with subcutaneous suma-triptan. Obstet Gynecol 1993; 82: 769-772. (Pubitemid 23312185)
27. Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous suma-triptan in the acute treatment of menstrual migraine. Obstet Gynecol 1995; 86: 911-916. (Pubitemid 27331483)
28. Silberstein S, Massious H, Jeunne C, Johnson-Pratt L, McCarroll K, Lines C. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000; 96: 237-242. (Pubitemid 30447346)
29. Massiou H, Jamin C, Hinzelin G. Efficacy of oral nara-triptan in the treatment of menstrually related migraine. Eur J Neurol 2005; 12: 774-781. (Pubitemid 41495134)
30. Schreiber C, Cady R. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg. Clin Ther 2007; 29(Suppl): 2511-2619.
31. Tuchman M, Hee A, Emeribe U, Silberstein S. Efficacy and tolerability of zolmitriptan oral tabley in the acute treatment of menstrual migraine. CNS Drugs 2006; 20: 1019-1026. (Pubitemid 44912709)
32. Landy S, Savani N, Shackelford S, Loftus J, Jones M. Efficacy and tolerability of sumatriptan tablets adminis-tered during the mild-pain phase of menstrually asso-ciated migraine. Int J Clin Prac 2004; 58: 913-919. (Pubitemid 39642611)
33. Nett R, Landy S, Shackelford S, Richardson M, Ames M, Lener M. Pain-free efficacy after treatment with sumatriptan in the mild pain phase menstrually associated migraine. Obstet Gynecol 2003; 102: 835-842. (Pubitemid 37206421)
34. Dowson A, Massiou H, Aurora S. Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan. J Headache Pain 2005; 6: 81-87. (Pubitemid 40667559)
35. Mannix L, Loder E, Nett R, et al. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia 2007; 27: 414-421. (Pubitemid 46632603)
36. MacGregor A, Igarashi H, Wilkinson M. Headaches and hormones: subjective versus objective assessment. Headache Quart 1997; 8: 126-136. (Pubitemid 27264171)
37. Loder E, Silberstein SD. Efficacy of zolmitriptan in the acute treatment of menstrually associated migraine. Headache 2004; 44: 120-130.
38. Becker W, Hew H, Christie S, Binder C. Topiramate pro-phylaxis and response to triptan treatment for acute migraine. Headache 2006; 46: 1424-1430. (Pubitemid 44556433)
39. Dodick D, Hulihan J, Wu S. Do migraine preventive medications enhance the efficacy of triptans? Analyses from topiramate migraine trials [abstract]. Headache 2005; 45: 820.
40. Bermejo P, Dorado R, Gomez-Arguelles J. Variation in almotriptan effectiveness according to different prophy-lactic treatments. Headache 2009; 49: 1277-1282.
41. Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G Efficacy and tolerability of almotriptann versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006; 27: S193-S197. (Pubitemid 44390141)
42. Brandes J, Poole A, Kallela M, et al. Short-term frova-triptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 2009; 29: 1133-1148.
43. Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medica-tion overuse. Headache 2008; 48: 1186-1193.
44. Loder E. Menstrual migraine: clinical considerations in light of revised diagnostic criteria. Neurol Sci 2005; 26: S121-S124. (Pubitemid 40796495)
45. Krymchantowski A, Adriano M, Fernandes D. Tolfe-namic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia 1999; 19: 186-187. (Pubitemid 29202151)
46. Krymchantowski A. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 2000; 58: 428-430. (Pubitemid 30469572)
47. Smith T, Sunshine A, Stark S, Littlefield D, Spruill S, Alexander J. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 2005; 45: 983-991.
48. Mannix L, Martin V, Cady R, et al. Combination treat-ment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol2009; 114: 106-113.
49. Silberstein S, Armellino J, Hoffman H, et al. Treatment of menstruation-associated migraine with the nonpre-scription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 1999; 21: 475-491. (Pubitemid 29198036)
50. Mannix LK, Savani N, Landy S, et al. Efficacy and toler-ability of naratriptan for short-term prevention of menstrually-related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 2007; 47: 1037-1049. (Pubitemid 47057222)
51. Newman L, Mannix LK, Landy S, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized double-blind, placebo-controlled study. Headache 2000; 41: 248-256.
52. Silberstein DD, Alkind AH, Schreiber C, Keywood C A randomized trial of frovatriptan for the intermittent pre-vention of menstrual migraine. Neurology 2004; 63: 261-269. (Pubitemid 38971124)
53. MacGregor E, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo controlled crossover study. Neurology 2006; 67: 2159-2163. (Pubitemid 46035469)